Immunology, Volume 168, Issue 1, Page 1-17, January 2023., 2023 In the past few years, the spectrum of monogenic systemic auto‐inflammatory diseases has widely expanded beyond the typical recurrent fever. Immuno‐haematological features, as cytopenias, hypogammaglobulinemia, hypereosinophilia, lymphoproliferation and immunodeficiency, have been described in association of several MSAID.
Hélène Vergneault +2 more
wiley +1 more source
Raised intracranial pressure and cerebral blood flow: 3. Venous outflow tract pressures and vascular resistances in experimental intracranial hypertension [PDF]
, 1974 I. H. Johnston, J. O. Rowan
openalex +1 more source
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT This study explores the differential expression of lncRNA PVT1 in intracranial aneurysms (IAs) and its role in the phenotypic switching of vascular smooth muscle cells (VSMCs). PVT1 and ALOX5 expressions in the serum of IA patients and healthy controls were detected by qRT‐PCR.
Yu‐Fei Cheng +4 more
wiley +1 more source
Efficacy of different hypertonic solutes in the treatment of refractory intracranial hypertension in severe head injury patients. A comparative study of 2 ml/kg 7.5% hypertonic saline and 2 ml/kg 20% mannitol [PDF]
The Indian Journal of Neurotrauma, 2007 A prospective, randomized study to evaluate the clinical benefit of increasing the osmotic load of the hypertonic solution administered for the treatment of refractory intracranial hypertension episodes in patients with severe head injury.
Nilay Chatterjee +5 more
doaj
Extracellular glutamate accumulates only in final, ischemic stage of progressive epidural mass lesion in cats [PDF]
, 2001 Epidural mass lesions may cause ischemia due to progressive intracranial hypertension. In order to 1) investigate the impact of intracranial pressure (ICP) on accumulation of neuroactive substances, and 2) test the significance of neurochemical ...
Dohmen, Christian +5 more
core
Letter: Benign intracranial hypertension associated with nitrofurantoin therapy. [PDF]
, 1974 Deepak B Sharma, Alan James
openalex +1 more source
Otolaryngologic Side Effects of GLP‐1 Receptor Agonists
The Laryngoscope, EarlyView.Objectives With the increasing use of GLP‐1 receptor agonist (GLP‐1 RA) drugs for weight loss and diabetes management, concerns have been raised regarding their potential side effects. We aim to assess the frequency of otolaryngologic adverse events (AEs). Study Design Retrospective analysis of national registry.
Faizaan I. Khan +11 more
wiley +1 more source
Effect of systemic arterial blood pressure on cerebral blood flow in intracranial hypertension. [PDF]
, 1975 F. Matakas, G. Eibs, J. Cuypers
openalex +1 more source
Genetic Risk Factors in Normal Pressure Hydrocephalus: What We Know and What Is Next
Movement Disorders, EarlyView.Abstract Knowledge of the genetic factors in normal pressure hydrocephalus (NPH) is rapidly evolving, with significant advances in recent years. We conducted a systematic review examining genetic contributions to NPH risk. Ovid Embase, Ovid Medline, Web of Science, and Cochrane Central were searched from inception through October 14, 2024, for human ...
Camila C. Piccinin +9 more
wiley +1 more source
THE EFFECT OF LORAZEPAM ON INTRACRANIAL PRESSURE AND CO2RETENTION IN CATS WITH INTRACRANIAL HYPERTENSION [PDF]
, 1979 Robert L. Gagnon +4 more
openalex +1 more source